Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease

Cancer Letters

Volumn 122, Issue 1-2, 1998, Pages 43-50

  Ohshima, Koichi ^a   Suzumiya, Junji ^a   Kanda, Motonobu ^a   Kato, Akiko ^a   Kikuchi, Masahiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Episomal EBV; Epstein barr virus (EBV); Integrated EBV

Indexed keywords

VIRUS DNA;

ARTICLE; B CELL LYMPHOMA; CHROMOSOME ABERRATION; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENOME; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; INTEGRATION; LEUKEMIA; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; SOUTHERN BLOTTING; T CELL LYMPHOMA; VIRUS INFECTION; VIRUS PARTICLE;

BLOTTING, SOUTHERN; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PLASMIDS; TUMOR VIRUS INFECTIONS; VIRUS INTEGRATION;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0032498250     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00368-6     Document Type: Article

References (22)

1. Rickinson A.B. Chronic, symptomatic Epstein-Barr virus infection. Immunol. Today. 7:1986;13-14.
2. Weiss L.M., Movahed L.A., Warnke R.A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 32:1989;502-506.
3. Korbjuhn P., Anagnostopoulos I., Hummel M., Tiemann M., Dallenbach F., Parwaresch M.R., Stein H. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood. 82:1993;217-223.
4. Kawa-Ha K., Ishihara S., Ninomiya T., Yumura-Yagi K., Hara J., Murayama F., Tawa A., Hirai K. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J. Clin. Invest. 84:1989;51-55.
5. Bayliss G.J., Wolf H. Epstein-Barr virus-induced cell fusion. Nature. 287:1980;164-165.
6. Hurley E.A., Agger S., Mcneil J.A., Lawrence J.B., Calendar A., Lenoir G., Thorley-Lawson D.A. When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J. Virol. 65:1991;1245-1254.
7. Gripenberg U., Levan A., Clifford P. Chromosomes in Burkitt lymphomas. Serial studies in cases with bilateral tumors showing different chromosomal stemlines. Int. J. Cancer. 4:1960;334-349.
8. Kripalani-Joshi S., Law H.Y. Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis. Int. J. Cancer. 56:1994;187-192.
9. Popescu N.C., Chen M.C., Simpson S., Solinas S., DiPaolo J.A. A Burkitt lymphoma cell line with integrated Epstein-Barr virus at a stable chromosome modification site. Virology. 195:1993;248-251.
10. Lestou V.S., Braekeleer M.D., Strehl S., Ott G., Gadner H., Ambros P.F. Non-random integration of Epstein-Barr virus in lymphoblastoid cell lines. Genes Chromosomes Cancer. 8:1993;38-48.
11. Ohshima K., Suzumiya J., Tasiro K., Mukai Y., Tanaka T., Kato A., Kikuchi M. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus negative Japanese. Am. J. Hematol. 52:1996;21-28.
12. Chang K.L., Chen Y.Y., Shibata D., Weiss L.M. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn. Mol. Pathol. 1:1922;246-255.
13. Raab-Traub N., Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 47:1986;883-889.
14. Cleary M.L., Nalesnik M.A., Shearer W.T., Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structures of genomic termini of the Epstein-Bar virus. Blood. 72:1988;349-352.
15. Brown M.A., Liu C., Garcia C.R., Wang Y.F., Griffith A., Sparkes R.S., Calame K.L. Clonal origins of lymphoproliferative disease induced by Epstein-Barr virus. J. Virol. 58:1986;975-978.
16. Ishihara S., Tawa A., Yumura-Yagi K., Murata M., Hara J., Yabuchi H., Hirai K., Kawa-Ha K. Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection. Jpn. J. Cancer Res. 80:1989;99-101.
17. Popescu N.C., Dipaolo J.A. Preferential sites for viral integration in mammalian genome. Cancer Genet. Cytogenet. 42:1989;157-171.
18. Wang J., Chenivesse X., Henglein B., Brechot C. Hepatitis B-virus integration in a cyclin-A gene in a hepatocellular carcinoma. Nature. 343:1990;555-557.
19. Shimizu N., Tanabe-Tochikura A., Kuroiwa Y., Tkada K. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J. Virol. 68:1994;6069-6073.
20. Wolf J., Jox A., Skarbek H., Pukrop T., Bartinitzke S., Pawlita M., Diehl V., Bullerdiek J. Selective loss of integrated Epstein-Barr virus genome after long-term cultivation of Burkitt's lymphoma×B-lymphoblastoid cell hybrids due to chromatin instability at the integration site. Virology. 212:1995;179-185.
21. Rowe M., Lear A.L., Croom-Carter D., Davies A.H., Rickinson A.B. Three pathways of Epstein-Barr virus gene activation from ENBA1 positive latency in B lymphocytes. J. Virol. 66:1992;122-131.
22. Cordier-Bussat M., Calender A., Vuillaume M., Bornkamm G.W., Lenoir G.M. Expression of the Epstein-Barr virus (EBV) latent membrane protein is tightly regulated, independently of EB nuclear antigen 2 of EBV integration or copy number. Virus Res. 27:1993;55-69.